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Abstract
Background: Since at least half of the genes in mammalian genomes are subjected to alternative splicing, alternative 
pre-mRNA splicing plays an important contribution to the complexity of the mammalian proteome. Expressed 
sequence tags (ESTs) provide evidence of a great number of possible alternative isoforms. With the EST resource for the 
domestic pig now containing more than one million porcine ESTs, it is possible to identify alternative splice forms of 
the individual transcripts in this species from the EST data with some confidence.
Results: The pig EST data generated by the Sino-Danish Pig Genome project has been assembled with publicly 
available ESTs and made available in the PigEST database. Using the Distiller package 2,515 EST clusters with candidate 
alternative isoforms were identified in the EST data with high confidence. In agreement with general observations in 
human and mouse, we find putative splice variants in about 30% of the contigs with more than 50 ESTs. Based on the 
criteria that a minimum of two EST sequences confirmed each splice event, a list of 100 genes with the most distinct 
tissue-specific alternative splice events was generated from the list of candidates. To confirm the tissue specificity of 
the splice events, 10 genes with functional annotation were randomly selected from which 16 individual splice events 
were chosen for experimental verification by quantitative PCR (qPCR). Six genes were shown to have tissue specific 
alternatively spliced transcripts with expression patterns matching those of the EST data. The remaining four genes had 
tissue-restricted expression of alternative spliced transcripts. Five out of the 16 splice events that were experimentally 
verified were found to be putative pig specific.
Conclusions: In accordance with human and rodent studies we estimate that approximately 30% of the porcine genes 
undergo alternative splicing. We found a good correlation between EST predicted tissue-specificity and experimentally 
validated splice events in different porcine tissue. This study indicates that a cluster size of around 50 ESTs is optimal for 
in silico detection of alternative splicing. Although based on a limited number of splice events, the study supports the 
notion that alternative splicing could have an important impact on species differentiation since 31% of the splice 
events studied appears to be species specific.
Background
EST assembly and mapping of expressed sequences onto
draft genomic sequences has resulted in large-scale
detection of alternative splicing. These studies indicate
that alternative splice events seem to be ubiquitous in
mammalian genomes. Between one-third and two-thirds
of human genes are estimated to produce at least two
alternatively spliced isoforms [1-6]. To date around
90,000 distinct alternative splicing events, in human
genes, have been predicted [7]. Even though a difference
in prevalence of alternative splicing between vertebrates
and invertebrate has been shown [8], several studies indi-
cate that there is no difference in prevalence among dif-
ferent mammalian species [8,9]. However, results
regarding the conservation of alternative splice events
between mammalian species have been conflicting [9-
11].
In addition to simply detecting the existence of alterna-
tive splice events from EST alignments, tissue annotation
of ESTs can be used for in silico prediction of the expres-
sion pattern of alternative transcripts [12-14]. Alternative
splicing of pre-mRNA, together with tissue-restricted gene
transcription, allows cells in multicellular organisms to
express the protein isoforms that are required for the spe-
cific function of each cell at different times and in different
tissues. Tissue and temporal restriction of transcription
and alternative splicing have similar requirements, as both
use specialised mechanisms utilising nucleotide sequences
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and proteins [15]. Alternative splicing of pre-mRNA can
contribute to the differences between tissues or cells either
by regulating gene expression or creating proteins with
various functions encoded by one gene.
Large scale EST detection of tissue-specific alternative
splicing in the human transcriptome has shown that 10-
30% of the alternatively spliced genes have evidence of
tissue-specific splice isoforms [16]. However, interpreta-
tion of EST data should be made with caution, even when
assuming that a wide variety of potential problems are
carefully filtered out, as for example genomic contamina-
tion and incomplete mRNA processing [17]. Individual
ESTs might represent rare splice forms or even errors
made by the splicing machinery that do not constitute a
significant fraction of transcript isoforms, or do not make
a correctly functional protein. Both cDNA synthesis tech-
niques and EST sequencing can give rise to incomplete
mRNA coverage, which may bias our perception of splic-
ing events. Furthermore, when alternative splice events
are found, information about their tissue-specific regula-
tion is often poor or unavailable [e.g. [12]].
Several databases of alternative splicing have been
developed. In general, these databases can be divided into
two categories, depending on the approach used. One
category of database uses existing annotations of alterna-
tive splicing by data mining sequences and literature from
databases such as EMBL, GenBank, Swiss-Prot and Med-
Line. This category includes 'Alternative Exon Database'
[18], 'Alternative Splicing Database' [19] and 'EST Derived
Alternative Splicing Database' [9]. Another category of
database examines alignments between EST/cDNA
sequences and genomic sequences, e.g. 'Putative Alterna-
tive Splicing Database' [20], 'The Alternative Splicing
Annotation Project' [21] and 'Alternative Splicing and
Transcript Diversity' [22]. All these databases differ in the
size of the generated data sets, the methods employed
and hence in their quality as a resource.
For more functionally predictive data, we suggest that
conservative criteria should be applied when using EST
data to predict tissue-specific alternative splice events. In
this study, we have used sequence information from a set
of cDNA libraries generated by the Sino-Danish Pig
Genome Project [23]. This resource contains sequence
data from 97 non-normalised libraries from 35 different
tissues and three different developmental stages. This
EST data set has been assembled together with publicly
available porcine EST sequences in a database (PigEST),
comprising more than one million EST sequences http://
pigest.ku.dk/.
Results
In silico detection of alternative splicing in the pig
The porcine database PigEST [23] contains 48,629 gene
clusters, however only 27,654 of them contain four or
more ESTs, which we require as a minimum for detecting
alternative splicing according to the selection criteria set
in the present study; as each splice variant has to be veri-
fied by at least two EST sequences. Putative alternatively
spliced transcripts were detected in 2,515 clusters. Thus,
disregarding cluster size we estimate that approximately
9% of the clusters in the PigEST database contain alterna-
tive splice variants. However, the relationship between
number of ESTs in each cluster and the number of ESTs
in clusters with alternative splicing indicate that approxi-
mately 30% of the porcine pre-mRNAs are subjected to
alternative splicing (see Figure 1). Most clusters contain
only two putative splice variants, but some clusters
appear to have more than ten. The average number of
putative splice variants in the porcine EST clusters con-
taining alternative splicing is 2,9.
Gene ontology
To address the issue of functional representations of the
s p l i c e  v a r i a n t s  i n  e a c h  l i b r a r y ,  a n n o t a t i o n  u s i n g  G e n e
Ontology (GO) was performed for each of the three main
classes of GO; molecular function, cellular component
and biological process [24]. The results of the GO analy-
sis are shown in Additional File 1 and detailed informa-
tion on the individual libraries is provided in Additional
File 2. The GO analysis shows an increase of alternative
splicing in the category "developmental and biological-
process-unknown" in the adult muscle libraries. Also, the
category "viral life cycle" is slightly overrepresented
Figure 1 Relationship between number of ESTs/cluster and per-
centage of clusters containing putative alternative splice events. 
The number of ESTs in clusters containing alternative splice events 
(with four as the minimum number of EST in a cluster) is shown at the 
x axis. The numbers at the y axis represents the percentages of clusters 
containing alternative splice events compared to the total number of 
clusters. The numbers at the data points refer to the bin of cluster size.
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among the alternatively spliced clusters in the lung librar-
ies. For cellular component there is an increase of alterna-
tive splicing in the category "extracellular matrix" in joint
capsule, eye and skin related libraries. In libraries origi-
nating from embryonic tissues an increase of alternative
splicing of "transcription-regulator-activity genes" is
observed.
In silico detection of tissue-specific alternative splicing in 
the pig
A total of 100 porcine genes with the most distinct tissue-
specific alternative splicing were selected out of 2,515
EST clusters with highest confidence. The list (shown in
the Additional File 3) was generated according to in silico
analysis of the EST data using conservative criteria. Tran-
scripts were only considered as an alternative splice vari-
ant if there were two or more ESTs that could confirm the
transcript variant. Hence, only clusters with four or more
transcripts were evaluated for alternative splicing. All
clusters containing alternative splicing can be found in
the PigEST Database at http://pigest.ku.dk/more/
altsplice
Validation of tissue-specific alternative splicing in pig
From the list of 100 putative tissue-specific alternatively
spliced genes, 10 genes, selected randomly from the list,
were validated experimentally with respect to the pre-
dicted alternative splice events (see Table 1). The tran-
script ratios for single alternative splice events were
studied in seven of the genes; ANAPC11, ATP5S, BSCL2,
EIF4E2, IGF2, HNRPLL and PPP3CC (for full gene names
and cluster names see Additional File 2). In CEP27 both
exon skipping of exon 5 and exon skipping of exons 4 and
5 together were examined. In the case of RBM4, two
independent splice events were studied involving alterna-
tive 3' splice site of exon 3 and skipping of exon 5 as well
as skipping of a part of exon 5. Finally, an exon skip of
several exons as well as a 5' alternative splice event were
studied in the AUH gene. Some of the genes are repre-
sented by additional putative alternative splice events, but
since they were not predicted to be tissue-specific
according to the in silico study they were not included in
the experimental validation.
In the present study, alternative splice-product ratios
are used as a quantitative measure of gene expression in
different tissues. Quantitative PCR (qPCR) amplification
of the two alternative splice transcript forms of a gene can
be used to calculate a ratio with good precision from
steady-state RNA samples. Stringent tissue-specific alter-
native splice events were defined as events in which one
splice variant was the major transcript of the gene in one
or more tissues whereas the other splice variant was
dominant in other tissues (illustrated in Figure 2A). In
addition, the ratio between two splice variants was
defined as tissue-restricted when one splice variant was
significantly up- or down-regulated in relation to the
other splice variant; however without one splice variant
being directly tissue-specific (illustrated in Figure 2B).
Comparisons of splice isoform ratios in different por-
cine tissues using qPCR showed that six genes (i.e.
ANAPC11,  ATP5S,  AUH,  CEP27,  EIF4E2,  IGF2) had
stringent tissue-specific alternative splice events, whereas
the remaining four genes (i.e BSCL2, HNRPLL, PPP3CC,
RBM4) were not expressed in an exclusive tissue-specific
manner, but statistically significant tissue-specific ratios
between alternative splice variants were detected. Exam-
ples of qPCR results for splice events with tissue-specific
and tissue-restricted alternative splice variants are shown
in Figure 3 and Figure 4, respectively. The ratios between
the alternative splice events in different porcine tissues
were statistically tested using a two-way ANOVA with
individual pigs as co-variable. The result of tissue-speci-
ficity is shown in Table 1. The majority of the variation
between the splice variants was found to be a result of tis-
sue-specific regulation. However, the two-way ANOVA
showed that the individual pigs also contribute signifi-
cantly to the variation with approximately one-fifth of the
total variation (data not shown).
The tissues tested for all alternative splice events were
colon, cortex, liver, muscle and spleen in addition to
selected tissues relevant for the specific gene according to
the in silico prediction of the tissue-specificity. Tissue-
specificity or tissue-specific ratio of the splice variants
were detected mostly in muscle/heart, intestine and
brain, but two cases of liver-specific and one case of
ovary-specific expression were also detected. The suc-
cessful use of the conservative criteria for in silico predic-
tion of splice events is reflected by the rate of
experimental verification: all of the 16 candidate splice
events studied experimentally were confirmed to be pres-
ent at levels that indicate functional importance (see
Table 1). Thus, in total five of the 16 alternative splice
events studied (~31%) appear to be species specific.
Cross-species studies using mouse or human ESTs have
shown high sequence and gene structure similarity [4,25].
Alignment of the porcine splice variants with mouse and
human genomic sequences showed several putative pig
specific splice variants. The porcine AUH gene produces
an alternative splice variant that is ovary specific. More-
over, no significant BLAST hit was found against
expressed sequences in other species. PPP3CC  has an
exon skip with an exon not defined in human, but a highly
conserved sequence of the exon was found in an intron of
the orthologous human PPP3CC gene. Similarly, the por-
cine BSCL2 gene produces two different transcripts with
distinct 5' initiation exon and one of the BSCL2 initiation
exons seems to be putative pig specific, but with a highly
orthologous sequence in the human BSCL2 gene assignedNygard et al. BMC Research Notes 2010, 3:123
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between exon 1 and 2. Two porcine genes, ANAPC11 and
IGF2, also produce transcripts with different 5' initiation
exon unique for pig and both of these transcript were
found to be liver-specific. Thus, in total five of the 16
alternative splice events studied (~31%) appear to be spe-
cies specific.
Discussion
The number of clusters with alternative splicing increases
with the number of ESTs per cluster as shown in Figure 1,
but attains a maximum between 50-300 ESTs per cluster.
Approximately one-third (30%) of the clusters with 50-
300 ESTs contain alternative splice variants. This esti-
mate is based on the assumption that the number of ESTs
and hence the coverage of the individual gene is more
important than expression level when the aim is to iden-
tify alternative splicing. A decrease is observed in clusters
with more than 300 ESTs, most likely explained by the
low number of clusters in this category. The results indi-
cate that a cluster size of at least 50 ESTs is optimal for
detection of alternative splicing. The estimated 30% por-
cine genes with alternative splicing are in agreement with
Table 1: Gene information on experimental verified splice variants.
Gene Tissue-specificity
No. Symbol Name Function EST qPCR P-value
4 IGF2 insulin-like growth factor 2 
(somatomedin A)
Cell 
proliferation
Liver Liver 5.5 × 10-27
7 EIF4E2 eukaryotic translation initiation 
factor 4E family member 2
Translation Intestine Intestine/
lymph
2.6 × 10-44
14 RBM4 RNA binding motif protein 4 Transcription Thymus
Brain
Brain* 7.2 × 10-36
1.9 × 10-9
15 ANAPC11 anaphase promoting complex 
subunit 11 homolog (yeast)
Cell cycle Muscle, 
Lymph - 
Brain - 
Intestine
Liver 9.7 × 10-5
27 ATP5S ATP synthase, H+ trans-porting, 
mitochondrial F0 complex, subunit 
s (factor B)
Ion 
transporter
Muscle Muscle 5.7 × 10-18
28 HNRPLL heterogeneous nuclear 
ribonucleoprotein L-like
RNA 
processing
Brain Brain* 1.0 × 10-21
41 PPP3CC protein phosphatase 3 (formerly 
2B), catalytic subunit, gamma 
isoform
Phophatase Brain Muscle* 2.1 × 10-42
71 CEP27 centrosomal protein 27 kDa Centrosome Brain Brain 7.8 × 10-18
3.3 × 10-15
85 BSCL2 Bernardinelli-Seip congenital 
lipodystrophy 2 (seipin)
unknown Ovary Ovary* 1.7 × 10-30
97 AUH AU RNA binding protein/enoyl-
Coenzyme A hydratase
RNA 
catabolism
Heart Heart*
Ovary
2.0 × 10-19
4.0 × 10-16
No. refers to the ranking on the predicted tissue-specific list (Additional File 2). Tissue specificity is listed both in regard to the in silico 
predictions (manual inspection of EST data) and in regard to the experimental verifications (qPCR). The P-value is referring to the ANOVA 
results. Tissues marked with * are not exclusive tissue-specific but tissue-specific ratios between the splice variants have been detected.Nygard et al. BMC Research Notes 2010, 3:123
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Figure 2 This figure illustrates how tissue-specific and tissue-restricted expression pattern of two splice events have been defined in the 
study. A) tissue-specific expression pattern is defined as one splice variant being dominant in some tissues whereas the other splice variant is domi-
nant in other tissues. B) tissue-restricted expression is defined as expression pattern where the ratio between two splice variants is significantly differ-
ent in different tissues, however always with the same splice variant as the dominant one.
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Figure 3 Gene structure and QPCR data for genes with validated tissue-specific or tissue-restricted alternatively spliced variants. QPCR data 
presented as changes in fold ratios between expressions of two splice variants in different adult pig tissues for the genes: ANAPC11, ATP5S, AUH, CEP27, 
EIF4E2 and IGF2. Data are normalised with a reference gene index. Values are geometric means ± Geometric S.E.M.; N = 4 animals. The highest ex-
pressed splice variant in the majority of the tissues is used as the numerator and the less expressed splice variant is used as the denominator. The 
highest expressed splice variant is shown in the upper part of the "Gene" column and the less expressed splice variant is showed in the lower part of 
the "Gene" column. *sequence that have not been defined as exon in any other species.
Gene QPCR  expression 
ANAPC11 
 
 
 
 
 
0,1
1
10
100
 
ATP5S 
 
 
0,1
1
10
 
AUH 
 
 
 
0,1
1
10
 
CEP27 
 
0,1
1
10
 
 
EIF4E2 
 
 
0,1
1
10
 
IGF2 
 
0,01
0,1
1
10
100
1000
10000
100000
 
1          2           3 
 1            *         2 
3      4     5       6 
 1           2            3 
1            *           2 
 7            *            8 Nygard et al. BMC Research Notes 2010, 3:123
http://www.biomedcentral.com/1756-0500/3/123
Page 7 of 12
Figure 4 Gene structure and QPCR data for genes that are neighed expressed in a tissue-specific manner nor in a tissue-restricted manner, 
however, with validated alternatively spliced variants. QPCR data presented as changes in fold ratios between expressions of two splice variants 
in different adult pig tissues for the genes: BSCL2, HNRPLL, PPP3CC and RBM4. Data are normalised with a reference gene index. Values are geometric 
means ± Geometric S.E.M.; N = 4 animals. The highest expressed splice variant in the majority of the tissues is used as the numerator and the less 
expressed splice variant is used as the denominator. The highest expressed splice variant is shown in the upper part of the "Gene" column and the 
less expressed splice variant is showed in the lower part of the "Gene" column. *sequence that have not been defined as exon in any other species.
 
Gene QPCR  expression 
BSCL2 
 
  1
10
100
1000
 
HNRPLL 
 
 
1
10
 
PPP3CC 
 
1
10
100
1000
 
RBM4 
 
 
 
1
10
100
1000
 
 
CEP27 
 
 
1
10
100
 
AUH 
 
 
 
1
10
100
 
1   2   3  4  5   6   7 
 10       11      12 
 1            *           2 
12          *         13 
 4           5          6 
 4           5           6 Nygard et al. BMC Research Notes 2010, 3:123
http://www.biomedcentral.com/1756-0500/3/123
Page 8 of 12
large-scale estimations of alternative splicing data based
on EST predictions in human and mouse. Human EST
comparisons showed that 35% [5] and 38% [1] of the
human genes had alternative splicing and in mouse the
frequency of alternative splicing was estimated to 33% of
the genes [26]. It is, however, important to note that
direct comparison between studies is difficult since strin-
gency of prediction may differ, e.g. using two versus one
EST to predict an alternative splice event and/or use of
different gap size. More recent studies of alternative splic-
ing estimate a larger proportion of human genes to have
alternative splice variant [3,4,27]. These studies are either
based on a combination of genomics sequence informa-
tion and EST data, or contain a greater amount of ESTs.
In addition, supplementary cDNA libraries from more
developmental and pathological stages will probably
increase the number of observed alternative splicing
e v e n t s  i n  p o r c i n e  g e n e s .  W e  n o t e  t h a t  i n  h u m a n  a n d
mouse, where alternative splicing is estimated to be most
prevalent, many cDNA libraries are cancer related and
hence many of the alternative splice variants that were
detected may have been pathological [28,29]. In contrast,
most porcine cDNA libraries are constructed from
healthy tissue [24,25,30-33].
Since our study is based on the use of EST consensus
sequences as well as sub-cluster construction with at least
two EST sequences, the reliability of the prediction of
alternative splicing is high. The consensus sequences
reconstruct parts of transcripts from multiple EST
sequences and so contain a lower number of sequencing
errors than the original EST data. Since consensus
sequences have been aligned to reveal putative splice sites
fewer splice site artefacts have been identified compared
to studies based only on EST alignments. The successful
use of the conservative criteria for in silico prediction of
splice events is reflected by the rate of experimental veri-
fication: all of the 16 candidate splice events studied
e x p e r i m e n t a l l y  w e r e  c o n f i r m e d  t o  b e  p r e s e n t  a t  l e v e l s
that indicate functional importance.
In total five of the 16 alternative splice events studied
(~31%) appear to be species specific. These findings are
comparable to human and rodent studies where it has
been estimated that 25% of human alternatively spliced
exons are not present in the orthologous murine genes
[9,34]. These studies also show that approximately half of
the alternatively spliced genes produce species-specific
isoforms. In addition, even more alternative splice events
that cannot be defined as species-specific have been
shown to be regulated in a species-specific manner [35].
It has been hypothesised that alternative splicing can be
used for creation of new exons and hence novel proteins,
since the majority of new exons have unique sequences in
the genome, suggesting that most new exons might origi-
nate from intronic sequences [36]. This is supported by a
comparison between human-mouse-rat alternative splic-
ing patterns suggesting that alternative splicing is associ-
ated with a large increase in the frequency of recent gain
or loss of exons [35]. Thus, it seems that species-specific
alternative splicing and species specific regulation of
expression provide important contributions to specia-
tion.
Conclusion
In accordance with human and rodent studies we esti-
mate that approximately 30% of the porcine genes
undergo alternative splicing. We found a good correlation
between EST predicted tissue-specificity and experimen-
tally validated splice events in different porcine tissue.
This study indicates that a cluster size of around 50 ESTs
is optimal for in silico detection of alternative splicing.
Although based on a limited number of splice events, the
study supports the notion that alternative splicing pro-
vides an important impact on species differentiation
since 31% of the splice events studied appears to be spe-
cies specific.
Methods
In silico data preparation
In total 2515 porcine genes (clusters) with putative alter-
native splice events were predicted using porcine EST
sequences available in the PigEST database and analysed
with the Distiller software as described by Gorodkin et al.
[23]. The ESTs assembled in a cluster were divided into
consecutive 12-mers by the consensus builder of Distiller.
The two consecutive 12-mers, taking SNPs into account,
were compared to detect variants [37]. A transcript is
considered as an alternative splice variant if there are two
or more ESTs that can confirm the transcript variant.
Hence, only clusters with four or more transcripts can be
evaluated for alternative splicing using this criterion. The
Distiller software will detect putative exon skips, 3' and 5'
alternative splicing as well as other rare splice categories,
but cannot give information on the actual splice type,
although gaps less than 40 bp are not detected as alterna-
tive splicing. Each of the putative candidate genes can
contain two or more different splice variants.
To obtain information of Gene Ontology (GO) on clus-
ters containing alternative splicing, GO analysis (UniProt
36.0 release) were performed for each of the three main
classes; molecular function, cellular component and bio-
logical process [24]. We are aware that GO categories
have been updated since the study by Gorodkin et al. [23]
was performed, however, for comparison the same cate-
gories were applied in this work. GO expression profiles
were constructed as followed; the expressions of alterna-
tive splicing of each of the categories were accumulated
for clusters containing alternative splicing and norma-
lised into fractions. For each library a log odds ratios ofNygard et al. BMC Research Notes 2010, 3:123
http://www.biomedcentral.com/1756-0500/3/123
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Table 2: Sub-cluster names (from the PigEST database) and primer sequences of experimentally verified splice variants.
Gene symbol Sub-cluster name Forward primer (5'T3') Reverse primer (5'T3') Amplicon
 length (bp)
IGF2 Ss1.1-Utr1-UTR01C050081.5SS AGCCCACAGCGATTCCAA AGTCTCACTGGGGCGGTAAG 110
Ss1.1-Liv1-LVR010049B06.5SS CCGGCTTCCAGATTCCAA AGTCTCACTGGGGCGGTAAG 143
EIF4E2 Ss1.1-Pig3-SRG8020J01.3SS CCGGTTTCAGGAGGACATTA GAAAGCTTGAATTGTCCTTGATG 164
Ss1.1-Tes1-TES01A030013.5S CCGGTTTCAGGAGGACATTA ACTCCTCCCAGGCCTTGAT 161
RBM4 Ss1.1-Lng1-LNG010007H10.5SS TCGGCATTGCGCGGCTGT CTCGAACAGTGAGCGGATCT 94
Ss1.1-Utr1-UTR010079B01.5S GATTTTCGTGCGGGCTGT CTCGAACAGTGAGCGGATCT 94
Ss1.1-Lng1-LNG010007H10.5SS CATCAGAGGCCTTGACAACA CGGCAACAGGTGTCGATAG 101
.1-Thy1-THY010092E11.5SS TCGTGAAAGATTATGCCTTCG CACACACATCCCACCTTGAA 101
Ss1.1-Utr1-UTR010079B01.5SS TCGTGAAAGATTATGCCTTCG CTCTTTCCCGCACCGATAGC 124
ANAPC11 Ss1.1-Pig4-TMW8023A04.5SS GTGGGCCTTGCAGGAGTT GAGCCACTTGAGGATGCAGT 246
Ss1.1-rnca27b_a11.5S CCGCGGTCGTTTATATACCT GAGCCACTTGAGGATGCAGT 276
Ss1.1-Pig3-SRG8012J07.3S TGGCTCCCAAGTGCTGTAG GAGCCACTTGAGGATGCAGT 267
ATP5S Ss1.1-ruio31_j9.5SS TCCCTTCGACGCTATCAAAT GATGCGTTCATGATCCACTTT 144
Ss1.1-Mixn-0026b16.5SS ACCAAGTGGCAAATCAAATG GATGCGTTCATGATCCACTTT 143
HNRPLL Ss1.1-rret19_c4.5S GATAAGAGTTCCCAATGGTTCC GGTAAACAAATTCTAACATGCTCTTC 101
Ss1.1-rpbfe0126_n23.5S TGAAAGTTTGATGAAGGGAACT GGTAAACAAATTCTAACATGCTCTTC 136
PPP3CC Ss1.1-LyN1-MLN01A040100.5 GATGAAATTGAAGGAGGCACT TCCCGAAGAATTGAAAAGACC 98
Ss1.1-Mixn-0001e03.5S AAGCTATCAGAAAGGAGGCACT TCCCGAAGAATTGAAAAGACC 99
CEP27 1Ss1.1-Liv1-LVRM10031B03.5SS CTAAAGAAAATGAGCACAGC TCTGTTGTTCTCGCCACTTG 97
2Ss1.1-rsug28_c19.5S GCTGTTTATCACAGAGCACAGC TCTGTTGTTCTCGCCACTTG 99
3Ss1.1-Pig4-TMW8033B03.3S CCTTCATTTTTGGAGCACAG TCTGTTGTTCTCGCCACTTG 98
BSCL2 Ss1.1-Thy1-THY010012C06.5 GGTGTGCAGAGACCAGATCA GGTTCAGGCCTTGAGTTCCT 117
Ss1.1-Spl1-SPL010003H07.5S GCTGCTCGCTCTGAGTCC GGTTCAGGCCTTGAGTTCCT 111Nygard et al. BMC Research Notes 2010, 3:123
http://www.biomedcentral.com/1756-0500/3/123
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the GO categories between the actual fractions and the
average fractions of clusters labelled with alternative
splicing were computed. A heat map of the log odds val-
ues (in bits) for each of the GO categories was con-
structed. This was done by comparing the actual fraction
of the GO categories with the respective average fractions
of ESTs from clusters labelled as alternative splicing.
EST sequences are assembled into clusters and divided
into sub-cluster representing different putative splice
variants. One hundred clusters with evidence of tissue, in
form of library, specific alternative splice event were gen-
erated based on the 2515 genes with presumed alterna-
tive splicing. The selected clusters contain at least one
pair of transcripts that satisfy the following criteria; 1)
pairs of transcripts from the same cluster (parent cluster)
where no more than 10% of the clones in either sub-clus-
ter come from the same libraries as the other sub-cluster
2) the best sub-cluster pairs were determined to be for
pairs where the smaller of the two sub-clusters contain
the highest fraction of the total ESTs. The consensus
sequences for both splice variants were used for compari-
son with genomic porcine sequences, if available, to
reveal the exon-intron structure. When no genomic por-
cine sequence was available, comparison of the pig
sequence with human and mouse genomic sequences was
used to obtain the gene structure, under the assumption
that the exon-exon boundaries are conserved between
human, mouse and pig.
Primer design
All the primers were designed using the Primer 3 soft-
ware [38]. The primers were designed to span one splice
site also candidate for an alternative splice site, an
approach which minimise inaccuracies in quantification
due to genomic DNA contamination. The secondary
structure of the amplicons were analyzed by Mfold using
the criteria -3<dG<0 [39] to optimize the PCR efficiency.
Primers and amplicons were in silico verified with
BLASTN for specificity and the size of the PCR products
were confirmed by gel electrophoresis and melting point
analysis during qPCR. Information of primer sequences
and sub-cluster names is found in Table 2.
Tissue collection and RNA extraction
Nineteen different porcine tissues were collected from
four (2 females and 2 males) 3 months old siblings (Dan-
ish crossbreds). Ovaries were collected from four 6-
months old female crossbreds. Total RNA was extracted
in duplicate for each tissue and animal using different
protocols depending on the tissue according to each
manufacturer protocol: TRIreagentR (Molecular
Research Centre, inc.) for stomach, lung, heart, kidney,
lymph node, colon, jejunum, illeum, duodenum, cartill-
age, spleen and skin. RNeasy Lipid Tissue Kit (Qiagen) for
adipose (subcutaneous), cortex cerebri, cerebellum, hip-
pocampus and ovary. RNeasy Fibrous Tissue Kit (Qiagen)
for muscle (longissimus dorsi). RNeasy maxi Kit (Qiagen)
for pancreas. RNeasy mini Kit (Qiagen) for liver. Contam-
inating genomic DNA was degraded by treatment with
RQ1 RNase-free DNase (Promega) according to the
instructions manual, followed by spin-column purifica-
tion (Qiagen RNeasy mini or micro cleanup kit). The
total RNA was quantified by optical density and the qual-
ity was evaluated by rRNA 28S/18S bands inspection by
gel electrophoresis and by RIN number (2100 Bioana-
lyzer, Agilent technologies). RIN of 5 was considered
minimum acceptable.
cDNA synthesis
Four μg of DNase-treated total RNA were reverse tran-
scribed at 42°C using Improm-II™ reverse trancriptase
(Promega) and a 3:1 mixture of Random hexamers and
Oligo-dT, according to the manufacturers recommenda-
tions. Prior to use in qPCR, cDNA was diluted 1:16 with
H2O. The panel consists of four biological replicates and
four experimental replicates for each tissue, in total 8
samples/tissue.
Quantitative PCR
Real-time RT-PCR was performed on a Mx3000 detec-
tion system (Stratagene). For each transcript as well as for
the reference genes, a serial of dilutions of the purified
PCR product generated for each specific primer pair was
done in order to build a standard curve. Single reactions
were prepared for each cDNA and for each dilution. Each
PCR also included a reverse transcription negative con-
trol to confirm the absence of genomic DNA, a non tem-
plate negative control to check for primer dimers and a
porcine genomic DNA control to verify no amplification
of genomic DNA with the primers. Briefly, 5 μL Quanti-
Fast SYBR Green PCR Master Mix (Qiagen, Hilden, Ger-
many) was mixed with 5 pmol of each primer and 2 μL of
AUH Ss1.1-Ova1-OVR010018B04.5SS CTACAGCTCTGAGGCGAAGA CACCACAATTCCTCGGTTCT 76
Ss1.1-Liv1-LVR010068B01.5S GGCAATTATTCCTGGTGGAG TCAAATGTTGCCTTTTCAGC 107
Ss1.1-Pig3-SRG8009K09.3S TGTCTCCTGTGCTGCAGTATG TGTGTGAGGGTACATGTGTGAA 108
Table 2: Sub-cluster names (from the PigEST database) and primer sequences of experimentally verified splice variants. (Continued)Nygard et al. BMC Research Notes 2010, 3:123
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diluted cDNA or water or dilution in PCR plates (AB
Gene, ThermoScientific, Waltham, MA) and underwent
PCR amplification (model Mx3000P, Stratagene, La Jolla,
CA). The cycling conditions were one cycle of denatur-
ation at 95°C/5 min, followed by 40 two-segment cycles
of amplification (95°C/10 sec, 60°C/30 sec). Fluorescence
was measured automatically during amplification and
one three-segment cycle (95°C/1 min, 60°C/30 sec, 95°C/
30 sec) was performed to obtain the melting curve for the
product. The baseline adjustment method of the thermo-
cycler (Mx3000, Stratagene) software was used to deter-
mine the quantities in each reaction. All samples were
amplified and the mean was used for further analysis.
Quantity values were normalised by a reference index
constructed from four reference genes; using YWHAZ,
TBP, RPL4 and BACT. The program geNorm [40] was
used for calculation of the reference index as well as for
selection of the four most suitable reference genes from a
panel of nine potential reference genes [41]. The specific-
ity of amplification was confirmed by DNA sequencing of
the PCR products. The amplified PCR products were
purified using QIAquick PCR Purification Kit (Qiagen)
and sequenced using BigDye®  Terminator v3.1 Cycle
Sequencing Kit (Applied Biosystems) on an ABI PRISM®
3130 Genetic Analyzer.
Data analysis/statistical analysis
Changes in fold ratio of mRNA expression between the
two splice variants was calculated as relative quantity val-
ues using the formula;   where
Esplice1 is the efficiency of qPCR for splice variant 1 and
Esplice2 for splice variant 2. Ctsplice1 and Ctsplice2 are the Ct
values for each sample. The efficiencies were calculated
based on the standard curve. The fold ratio change was
LOG transformed according to Gallup and Ackermann
[ 4 2 ]  t o  g e n e r a t e  n o r m a l  d i s t r i b u t i o n  a n d  t h e  d a t a  w a s
tested for statistical significance of differential mRNA
expression between the splice variants using two-way
ANOVA with tissue as well as pig individual and sex as co
variables. T-test was performed if the main effect was sig-
nificant.
N = 4 was calculated as a mean of the two biological
replicates from each animal. A P value of < 0.05 was con-
sidered statistically significant. The geometric means and
the geometric standard error of the mean (S.E.M) were
calculated.
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